MANA Advisors LLC lessened its position in shares of Albemarle Co. (NYSE:ALB) by 70.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,853 shares of the specialty chemicals company’s stock after selling 6,648 shares during the quarter. MANA Advisors LLC’s holdings in Albemarle were worth $265,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in ALB. Aperio Group LLC raised its stake in shares of Albemarle by 7.0% during the 4th quarter. Aperio Group LLC now owns 42,819 shares of the specialty chemicals company’s stock worth $5,476,000 after buying an additional 2,788 shares during the last quarter. SeaCrest Wealth Management LLC acquired a new position in shares of Albemarle during the 4th quarter worth $103,000. Public Employees Retirement Association of Colorado raised its stake in shares of Albemarle by 3.3% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 22,269 shares of the specialty chemicals company’s stock worth $2,848,000 after buying an additional 704 shares during the last quarter. Alps Advisors Inc. acquired a new position in shares of Albemarle during the 4th quarter worth $255,000. Finally, Stephens Inc. AR acquired a new position in shares of Albemarle during the 4th quarter worth $115,000. 86.30% of the stock is owned by institutional investors and hedge funds.

ALB opened at $95.74 on Wednesday. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.48 and a quick ratio of 1.72. The stock has a market capitalization of $10.56 billion, a price-to-earnings ratio of 20.86, a price-to-earnings-growth ratio of 1.12 and a beta of 1.63. Albemarle Co. has a 12 month low of $86.75 and a 12 month high of $144.99.

Albemarle (NYSE:ALB) last posted its quarterly earnings results on Wednesday, May 9th. The specialty chemicals company reported $1.30 EPS for the quarter, beating the consensus estimate of $1.20 by $0.10. The company had revenue of $821.60 million during the quarter, compared to analysts’ expectations of $798.20 million. Albemarle had a return on equity of 13.80% and a net margin of 4.27%. The firm’s revenue was up 13.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.05 EPS. sell-side analysts forecast that Albemarle Co. will post 5.25 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, July 2nd. Shareholders of record on Friday, June 15th will be issued a $0.335 dividend. This represents a $1.34 annualized dividend and a yield of 1.40%. The ex-dividend date is Thursday, June 14th. Albemarle’s dividend payout ratio (DPR) is 29.19%.

Several research firms have recently issued reports on ALB. Morgan Stanley downgraded Albemarle from an “equal weight” rating to an “underweight” rating and set a $85.00 price target for the company. in a research note on Monday, February 26th. Argus began coverage on Albemarle in a research note on Friday, February 23rd. They set a “buy” rating and a $148.00 price target for the company. Berenberg Bank began coverage on Albemarle in a research note on Tuesday, February 27th. They set a “buy” rating and a $150.00 price target for the company. Zacks Investment Research cut Albemarle from a “buy” rating to a “hold” rating in a research report on Friday, May 18th. Finally, KeyCorp reiterated an “overweight” rating and set a $148.00 price objective (down previously from $150.00) on shares of Albemarle in a research report on Thursday, March 1st. One research analyst has rated the stock with a sell rating, five have issued a hold rating and twenty-one have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $124.16.

Albemarle Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium and Advanced Materials segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and automobiles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets.

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.